Exercise Shares
Exercise Shares. [158,999,371]1 shares of common stock of Evofem, par value $0.001 per share, issuable upon exercise of this Warrant (subject to adjustment as set forth in Section 1.12(b) of the Agreement and Plan of Merger, dated as of the date hereof, among Evofem, Neothetics and the other parties thereto (the "Merger Agreement"))
Found in
Evofem Biosciences, Inc. contract
Exercise Shares. Shares of Company Common Stock
Found in
Massive Interactive, Inc. contract
Exercise Shares. Shall mean the Ordinary Shares issuable upon exercise of this Warrant.
Found in
Quotient Ltd contract
Exercise Shares. (a) if this Warrant is exercised pursuant to Section 3(a) hereto, Next Equity Shares, or (b) if this Warrant is exercised pursuant to Section 3(b) hereto, Series B Preferred Stock.
Found in
SURGIQUEST INC contract
Exercise Shares. Shares of the Company's C Preference Shares issuable upon exercise of this Warrant.
Found in
Quotient Ltd contract
Exercise Shares. The shares of the Exercise Stock issuable upon exercise of this Warrant.
Found in
IFAN FINANCIAL, INC. contract
Exercise Shares. The number of shares of Warrant Stock equal to ten percent (10%) of the Principal Amount divided by either (i) the 90% of the applicable Exercise Price, if the Warrant Stock is Next Round Stock of Common Stock or (ii) $1.35, if the Warrant Stock is the Company's Series E-5 Preferred Stock, rounded down to the nearest whole share, subject to further adjustment pursuant to Section 5 below
Found in
Revance Therapeutics, Inc. contract
Exercise Shares. (i) up to 47,191 shares of the Company's Series D Preferred Stock (the "Series D Stock"), or (ii) if all outstanding Series D Stock has been automatically converted pursuant to Section 5 of the Company's Amended and Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), that number of shares of common stock of the Company, par value $0.001 per share (the "Common Stock"), into which the Series D Stock would have been converted immediately prior to such date of...
View More
Found in
Revance Therapeutics, Inc. contract
Exercise Shares. [ ] shares of Common Stock of Company, par value $0.001 per share (the "Common Stock"), subject to further adjustment pursuant to Section 5 below.
Found in
Revance Therapeutics, Inc. contract
Exercise Shares. Shall mean shares of the Company's Common Stock.
All Definitions
Found in
Bone Biologics Corp contract